PO:18:271 | Managing concomitant sle and psoriasis: the role of anifrolumab in a clinical case
Background. Systemic Lupus Erythematosus (SLE) is a chronic systemic autoimmune disease characterized by the interaction of genetic, environmental, and immunological factors. The type I interferon (IFN-I) pathway, particularly IFN-alpha, represents a central element in its pathogenesis. IFN-I is pr...
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
PAGEPress Publications
2025-11-01
|
| Serie: | Reumatismo |
| Soggetti: | |
| Accesso online: | https://www.reumatismo.org/reuma/article/view/2047 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|